Average resistance time to cabozantinib

Cabozantinib is a tyrosine kinase inhibitor. The average resistance time is half a year to one year, depending on the patient's condition. Cabozantinib is indicated for the treatment of progressive metastatic medullary thyroid carcinoma (MTC) and in combination with nivolumab for the treatment of advanced renal cell carcinoma (RCC). First-line treatment for hepatocellular carcinoma(HCC) patients who have previously received sorafenib, for adults with locally advanced or metastatic differentiated thyroid cancer that has progressed after previous VEGFR targeted therapy(DTC )and adults who are refractory or ineligible for radioactive iodine.

Discontinue cabozantinib treatment at least3 weeks before scheduled surgery (including dental surgery). Do not useCabosomantinib capsules instead ofCaboozantinib tablets. The recommended dose of cabozantinib is 60 mg orally once daily. METEOR - 331 patients with renal cell carcinoma treated with cabozantinib 60 mg once daily had a median duration of treatment of 7.6 months. Patients with advanced renal cell carcinoma were treated with cabozantinib 60 mg once daily for a median duration of 6.5 months. 467 patients with advanced liver cancer were treated with carboplatin 60 mg 1 times a day, and the median treatment duration was 3.8 months. 320pts with previously untreated advanced renal cell carcinoma received cabotinib 40 mgonce daily and Opdivo 240 mgevery 2 weeks30 minutes of treatment, with a median treatment duration of 20.2months. Lao ASEAN Pharmaceuticals, United Pharmaceuticals, Lucius Pharmaceuticals, Element Pharmaceuticals, etc. are produced, and the cost per box is less than 20mg*90pills1,000 yuan. The retail price of Everest Pharmaceuticals, Yaopin International and Beacon Pharmaceuticals in Bangladesh is around 20mg*90 capsules 2000 per box. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.